Margarete Schön

557 total citations
8 papers, 399 citations indexed

About

Margarete Schön is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Margarete Schön has authored 8 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Margarete Schön's work include Retinoids in leukemia and cellular processes (2 papers), Immunotherapy and Immune Responses (2 papers) and Autophagy in Disease and Therapy (1 paper). Margarete Schön is often cited by papers focused on Retinoids in leukemia and cellular processes (2 papers), Immunotherapy and Immune Responses (2 papers) and Autophagy in Disease and Therapy (1 paper). Margarete Schön collaborates with scholars based in Germany, Sweden and Denmark. Margarete Schön's co-authors include Michael P. Schön, James G. Rheinwald, Mosaad Megahed, Robert Kubitza, Thomas Ruzicka, Christina M. Parker, Percy Lehmann, Bernhard Homey, Joerg Buddenkotte and Stephan Seeliger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Investigative Dermatology.

In The Last Decade

Margarete Schön

8 papers receiving 392 citations

Peers

Countries citing papers authored by Margarete Schön

Since Specialization

Citations

This map shows the geographic impact of Margarete Schön's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margarete Schön with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margarete Schön more than expected).

Fields of papers citing papers by Margarete Schön

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margarete Schön. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margarete Schön. The network helps show where Margarete Schön may publish in the future.

Co-authorship network of co-authors of Margarete Schön

This figure shows the co-authorship network connecting the top 25 collaborators of Margarete Schön. A scholar is included among the top collaborators of Margarete Schön based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margarete Schön. Margarete Schön is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Treatment with diphenyl–pyrazole compound anle138b/c reveals that α-synuclein protects melanoma cells from autophagic cell death 2017 ·Proceedings of the National Academy of Sciences ·(unknown), Diana F. Lázaro, Sergey Ryazanov, Andrei Leonov, Armin Giese, Margarete Schön, Michael P. Schön, Christian Griesinger, Tiago F. Outeiro, Donna J. Arndt‐Jovin, Dorothea Becker	26
2	Damage-induced DNA replication stalling relies on MAPK-activated protein kinase 2 activity 2013 ·Proceedings of the National Academy of Sciences ·(unknown), (unknown), Margarete Schön, (unknown), Ingegerd Elvers, Dominique Kranz, (unknown), M. Menon, David Walter, Claus Storgaard Sørensen, Matthias Gaestel, Thomas Helleday, Michael P. Schön, Matthias Dobbelstein	59
3	NF-κB Inhibition through Proteasome Inhibition or IKKβ Blockade Increases the Susceptibility of Melanoma Cells to Cytostatic Treatment through Distinct Pathways 2009 ·Journal of Investigative Dermatology ·(unknown), Michael P. Schön, (unknown), Katrin Wallbrecht, Luise Erpenbeck, Margarete Schön	25
4	Proteinase-Activated Receptor-2 (PAR2): A Tumor Suppressor in Skin Carcinogenesis 2007 ·Journal of Investigative Dermatology ·Anke Rattenholl, Stephan Seeliger, Joerg Buddenkotte, Margarete Schön, Michael P. Schön, Sonja Ständer, Nathalie Vergnolle, Martin Steinhoff	39
5	The small-molecule immune response modifier imiquimod – its mode of action and clinical use in the treatment of skin cancer 2006 ·Expert Opinion on Therapeutic Targets ·Michael P. Schön, Margarete Schön	22
6	Reliability of diagnosis of melanoma in situ 2002 ·The Lancet ·Mosaad Megahed, Margarete Schön, (unknown), Michael P. Schön	71
7	Role of Integrin αE(CD103)β7 for Tissue-Specific Epidermal Localization of CD8+ T Lymphocytes 2001 ·Journal of Investigative Dermatology ·(unknown), Margarete Schön, Robert Kubitza, Bernhard Homey, (unknown), Percy Lehmann, Thomas Ruzicka, Christina M. Parker, (unknown)	115
8	A Limited Role for Retinoic Acid and Retinoic Acid Receptors RARα and RARβ in Regulating Keratin 19 Expression and Keratinization in Oral and Epidermal Keratinocytes 1996 ·Journal of Investigative Dermatology ·Margarete Schön, James G. Rheinwald	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact